Skip to main content
main-content

20-01-2021 | Urothelial cancer | Video

Key results on urothelial carcinoma presented at ASCO GU 2021

Speakers: Frederik Liedberg and Thomas Powles

Fredrik Liedberg and Thomas Powles discuss their thoughts on the game-changing results on metastatic urothelial carcinoma presented at ASCO GU. They cover updates on EV-301, JAVELIN Bladder 100, and their preferences on treatment sequencing. Also, they talk about the importance of CheckMate 274 in nonmetastatic patients, and discuss potential future approaches in this setting (15:35).

This activity is supported by an educational grant from Pfizer and Merck Healthcare KGaA, Darmstadt, Germany.

ESMO Congress 2021

Access our ongoing coverage including the latest news and expert video interviews.

Image Credits